Although there are no published reports of ketoacidosis specifically with dapagliflozin, it can be assumed that this is a class effect due to inappropriate prescriptions in patients with insufficient insulin (either endogenous or exogenous) and in which ketoacidosis has been masked by concomitant euglycaemia [74]. This evidence concerns the gene INS and type 2 diabetes mellitus.